Skip to main content
Fig. 3 | Journal of Ovarian Research

Fig. 3

From: RETRACTED ARTICLE: The role of apatinib combined with paclitaxel (aluminum binding type) in platinum-resistant ovarian cancer

Fig. 3

Effects of different doses of nab-P combined with AP on BALB/c. a Growth curve of subcutaneous tumor in four groups of mice, 0 d repressed the first day of drug intervention, b mice and volume of tumor after exfoliation, c the Bax, bcl-2, CD31, p-VEGFR-2 and MMP-2 protein expression of different groups by Western blot, d the Bax, bcl-2, CD31, p-VEGFR-2 and MMP-2 protein expression of different groups by Immunofluorescence (400x), e the Bax, bcl-2, CD31, p-VEGFR-2 and MMP-2 protein expression of different groups by Immunohistochemistry (400x). Note: *P < 0.05, **P < 0.01, medication group vs control group, △P < 0.05, △△P < 0.01, comparison of two sets of data

Back to article page